Skip Ribbon Commands
Skip to main content
CIBMTR

Study Lists

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   /   Studies   /   Clinical Outcomes Research   /   Study Lists   /   Observational Study
  • Print
  • Share

 


Recently Completed Studies

Study # CK17-02
Study Status: Published
Working Committee: Chronic Leukemia

Citation

Oran B, Ahn KW, Fretham C, Beitinjaneh A, Bashey A, Pawarode A, Wirk B, Scott BL, Savani BN, Bredeson C, Weisdorf D, Marks DI, Rizzieri D, Copelan E, Hildebrandt GC, Hale GA, Murthy HS, Lazarus HM, Cerny J, Liesveld JL, Yared JA, Yves-Cahn J, Szer J, Verdonck LF, Aljurf M, van der Poel M, Litzow M, Kalaycio M, Grunwald MR, Diaz MA, Sabloff M, Kharfan-Dabaja MA, Majhail NS, Farhadfar N, Reshef R, Olsson RF, Gale RP, Nakamura R, Seo S, Chhabra S, Hashmi S, Farhan S, Ganguly S, Nathan S, Nishihori T, Jain T, Agrawal V, Bacher U, Popat U, Saber W. Fludarabine and melphalan compared with reduced doses of busulfan and fludarabine improve transplantation outcomes in older patients with myelodysplastic syndromes. Transplantation and Cellular Therapy. 2021 Nov 1; 27(11):921.e1-921.e10. doi:10.1016/j.jtct.2021.08.007. Epub 2021 Aug 14.

Presentation(s)

2019, ASH

PubMed
PMID: 34403791
Abstract

Working Committee Contact

Kathleen Sobocinski ()
ksobo@mcw.edu
Last Updated: 10/29/2010 4:55 PM
CIBMTR